Update proposed implementation.html

wiki/pages/proposed implementation.html

@@ -22,7 +22,7 @@
 
     <div class="col-lg-9 col-md-9">
         <h1 id="Overview">Overview</h1>
-        <hr>
+        <hr style="width:900px">
 
         <p style = "padding-left: 5%; padding-right: 5%">
             
@@ -40,32 +40,32 @@
         </p>
 
         <h1 id="End Users">Who are the end users?</h1>
-        <hr>
+        <hr style="width:900px">
 
         <p> The primary end users of our project are epidemiologists and researchers who have actively contributed to its development. Through their collaboration and insights, we have gained a broader perspective on pathogen detection in mosquitoes and the direct transmission of critical information.</p>
 
 
         <h1 id="Secondary Users">Who are our secondary users</h1>
-        <hr>
+        <hr style="width:900px">
 
         <p> We have taken our project a step further by developing a user-friendly paper-based test that can be accessible to the general public. Our ultimate objective is to market the final test to private pharmaceutical companies. The test results can be seamlessly integrated into a dedicated application that we plan to design. This application will enable direct communication with epidemiologists, facilitating a rapid and efficient surveillance system.</p>
 
         <h1 id="Design">How to make the design user-friendly</h1>
-        <hr>
+        <hr style="width:900px">
 
         <p> To generate widespread awareness about our device, we conducted public surveys and engaged with individuals from various backgrounds. The paper-based test will be accompanied by a user-friendly manual, simplifying the chemical usage process. Users only need to add the specified chemicals, and upon receiving a signal (positive or negative), they can input the data into the application. The application will then automatically alert epidemiologists and researchers. Our goal is to ensure the affordability of these tests for the general public, making them accessible to a broad audience.</p>
 
         <p> The collected data will be stored in a database, serving as the foundation for model development to assess the severity of outbreaks. Subsequently, government entities, public health organizations, and researchers can collaborate to devise effective strategies for controlling the spread of epidemics.</p>
 
         <h1 id="Safety">What are the safety aspects we need to consider before making a product available to the public?</h1>
-        <hr>
+        <hr style="width:900px">
 
         <p> Prior to making the tests available to the public, we have taken meticulous steps to ensure strict adherence to safety regulations. Right from the project's inception, we have been committed to not violating any GMO regulations. During our in-vivo experiments in the laboratory, we employed mosquitoes infected with the virus, but it's crucial to note that the virus used was deactivated. In this regard, we worked closely with virologists, specifically Dr. Christophe Paupy from MIVEGEC in Montpellier, who provided detailed guidance on virus deactivation procedures.</p>
 
         <p> To maintain safety standards, the kits we provide to users will include materials for deactivating the virus. Additionally, we will supply gloves and strongly recommend the use of lab coats as precautionary measures. In our automated device, the chemicals will be automatically mixed, and the reactions performed, with the information transmitted directly to researchers, further ensuring safety and accuracy.</p>
 
         <h1 id="Considerations">What are the additional considerations for succesful deployement of the project</h1>
-        <hr>
+        <hr style="width:900px">
 
 
         <p style = "padding-left: 5%; padding-right: 5%">